📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2. (2022)

First Author: Pattni K
Attributed to:  Impact of network-structured populations on evolution funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12879-022-07239-z

PubMed Identifier: 35307024

Publication URI: http://europepmc.org/abstract/MED/35307024

Type: Journal Article/Review

Volume: 22

Parent Publication: BMC infectious diseases

Issue: 1

ISSN: 1471-2334